|
DERL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.33764177091234E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08529996101225E-09 |
| Normal-vs-Stage2 |
3.444800E-04 |
| Normal-vs-Stage3 |
3.32067706665384E-13 |
| Normal-vs-Stage4 |
2.41706654691143E-12 |
| Stage1-vs-Stage2 |
4.081400E-01 |
| Stage1-vs-Stage3 |
6.536900E-03 |
| Stage1-vs-Stage4 |
4.370000E-04 |
| Stage2-vs-Stage3 |
8.978700E-03 |
| Stage2-vs-Stage4 |
1.242090E-03 |
| Stage3-vs-Stage4 |
1.421590E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.53557200078103E-13 |
| Normal-vs-AfricanAmerican |
1.222470E-03 |
| Normal-vs-Asian |
1.89880000611709E-09 |
| Caucasian-vs-AfricanAmerican |
9.944800E-01 |
| Caucasian-vs-Asian |
5.966000E-01 |
| AfricanAmerican-vs-Asian |
8.403800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.43439995834183E-09 |
| Normal-vs-Female |
1.02600150597709E-11 |
| Male-vs-Female |
7.663400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.83950005122813E-09 |
| Normal-vs-Age(41-60Yrs) |
9.98368054894172E-12 |
| Normal-vs-Age(61-80Yrs) |
1.32300004285213E-09 |
| Normal-vs-Age(81-100Yrs) |
1.111840E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.443400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.893400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.308800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.180200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.993400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.119400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.05680000306307E-08 |
| Classical-VS-Follicular |
3.96099999999677E-05 |
| Classical-VS-Other |
9.659600E-01 |
| Classical-VS-Normal |
1.62825308791525E-12 |
| Tall-VS-Follicular |
4.88875606663441E-12 |
| Tall-VS-Other |
1.220430E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.029800E-01 |
| Follicular-VS-Normal |
3.237700E-02 |
| Other-VS-Normal |
1.576140E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.78810000537067E-08 |
| Normal-vs-N1 |
4.96909957625746E-10 |
| N0-vs-N1 |
1.080100E-02 |
|
|
